Loading
Elliptic Laboratories ASA Stock: price and insider trades · Norway
No insider purchase over the last 90 days. The latest was filed 09 Sept 2022.
Elliptic Laboratories ASA: what insiders have been doing
This page follows insider dealings at Elliptic Laboratories ASA as filed with Oslo Børs, a company from the Technology sector. 3 insiders have disclosed 5 filings since 18 October 2025.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
There has been no open-market purchase by an insider of Elliptic Laboratories ASA for at least a year.
For context, the typical company on the same exchange (median of 258 companies) published 4 filings over the same period, against 5 filings here. Over the whole record (from 2021), the tally stands at 6 purchases and 6 sales.
In the same sector, recent insider purchases at Gitlab Inc. and Baozun Inc. also feature in our signals. Every figure here comes from the filings published by Oslo Børs and describes the past, not future prices; it is not investment advice.
Insider Decl.
30
Thresholds
n/a
Buy Volume
€177,117
6 ops. · all time
Sell Volume
€3M
6 ops. · all time
Who traded when
BuySaleLaila Danielsen1 sale
Since the insiders bought
- Unknown insider (ELABS)-18.7%Entry NOK 18.22 · Close at T+365 NOK 14.82
- -23.1%Entry NOK 23.70 · Close at T+365 NOK 18.22
- -28.6%Entry NOK 24.80 · Close at T+365 NOK 17.70
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analyst consensus: bullish or bearish?
Analysts rate Elliptic Laboratories ASA Buy (bullish), based on 1 analysts. Average price target: NOK 4.80.
Fundamental score
Ranked 23,525 of 24,158 companies
11.6
score / 100
Value15
Quality9
FCF yld-5.7%
Earn yld-34%
EV/EBITDA·
ROE-59%
Gross mgn11%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
NOK 3.23
Analyst consensus
1 analystsBuy
NOK 4.80Target NOK 4.80(+49%)NOK 4.80
Income statement
RevenueNOK 101.3M
Gross profitNOK 10.9M11% margin
EBITDA-NOK 33.2M-33% margin
Net income-NOK 140M-192.0% margin
Valuation
PER (forward)-146.0x
P/Book1.9x
Beta0.82
Balance sheet & cash
Market capNOK 408.1M
Total debtNOK 13.1M
Free Cash Flow-NOK 23.1M
Debt / Equity6%
Profitability & ownership
ROE-59.3%
ROA-14.4%
% insiders23.2%
% institutions35.7%
Last declaration on 10 June 2026
Declarations30 total
OptionXOSLOSLO:675876
@ €0.2949OptionXOSLOSLO:675532
@ €0.2856OptionXOSLOSLO:674818
ShareXOSLOSLO:669631
24,000 shares@ NOK 8.20100.0% of flowOptionXOSLOSLO:660122
2,000,000 shares@ NOK 11.5287100.0% of flowOptionXOSLOSLO:654152
OptionXOSLOSLO:647900
300,000 shares@ NOK 13.304768.9% of flowOptionXOSLOSLO:620773
OptionXOSLOSLO:620415
OptionXOSLOSLO:620410
110,490 shares@ NOK 16.5431.1% of flowOptionXOSLOSLO:605314
@ €1.276OptionXOSLOSLO:604961
37,560 shares@ NOK 16.677.3% of flowOptionXOSLOSLO:595751
37,560 shares@ NOK 15.006.6% of flowOptionXOSLOSLO:595391
OptionXOSLOSLO:591712
250,000 sharesShareXOSLOSLO:579770
100,000 shares@ NOK 17.78100.0% of flowShareXOSLOSLO:570916
Canonical exit: 8 Dec 2022 (T+90)
OptionXOSLOSLO:556224
25 of 30 declarations
About Elliptic Laboratories ASA
Elliptic Laboratories ASA is a technology company focused on developing AI-based detection and interaction solutions. It is listed on the XOSL market.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
